View |
|
DR-XY46286
|
Phenylpropanolamine HCl + Paracetamol
|
No Drowse Decolgen 325
|
25mg/ 325mg
|
Tablet
|
Nasal Decongestant/Analgesic/Antipyretic
|
PT Medifarma Laboratories
|
Indonesia
|
Renewal
|
21 March 2023
|
13 March 2028
|
View |
|
DR-XY46287
|
Phenylephrine Hydrochloride + Paracetamol
|
Neozep Non-Drowsy 325
|
10mg/ 325mg
|
Tablet
|
Nasal Decongestant/Analgesic/Antipyretic
|
PT Medifarma Laboratories
|
Indonesia
|
Automatic Renewal
|
13 March 2023
|
13 March 2028
|
View |
|
DR-XY46290
|
Atropine Sulfate
|
Atrex
|
1mg/ mL
|
Solution for Injection
|
Anticholinergic
|
Grand Pharmaceutical (China) Co., Ltd.
|
China
|
Automatic Renewal
|
05 April 2023
|
13 April 2028
|
View |
|
DR-XY46292
|
Multivitamins + Minerals + Amino Acids
|
None
|
See Formulation
|
Tablet
|
Vitamin
|
United Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
08 July 2022
|
10 April 2028
|
View |
|
DR-XY46296
|
Silver Sulfadiazine
|
Silvertin
|
10 mg/g (1% w/w)
|
Cream
|
-
|
Antila Lifesciences Pvt. Ltd.
|
INdia
|
-
|
20 December 2023
|
05 April 2028
|
View |
|
DR-XY46299
|
Dextrose 5% in 1/2 (0.45%) Normal Saline
|
None
|
[see reverse for formulation]
|
Solution
|
Rehydration Solutions
|
A.N.B. Laboratories Co., Ltd.
|
Thailand
|
Automatic Renewal
|
15 June 2023
|
21 June 2028
|
View |
|
DR-XY46300
|
Thiamine Hydrochloride + Pyridoxine Hydrochloride + Cyanocobalamin
|
None
|
100mg/ 20mg/ 200mcg
|
Film-Coated Tablet
|
Vitamins
|
Hizon Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
19 May 2023
|
26 March 2028
|
View |
|
DR-XY46303
|
Cefuroxime (As Axetil) + Clavulanate Potassium
|
Cefuclav
|
500 mg/125 mg
|
Film-Coated Tablet
|
Antibacterial
|
Theon Pharmaceuticals Ltd.
|
India
|
Initial (Compliance)
|
28 March 2018
|
28 March 2025
|
View |
|
DR-XY46304
|
Budesonide
|
Cortiment
|
9mg
|
Tablet
|
Ulcerative Colitis
|
Cosmo S.P.A.
|
Italy
|
Monitored Release
|
04 April 2018
|
04 April 2025
|
View |
|
DR-XY46305
|
Multivitamins + Herbs + Choline bitartrate + Alpha-lipoic acid + CoEnzyme Q10 + Lycopene
|
Vita-Antioxidant
|
[see reverse]
|
Tablet
|
Vitamins
|
USANA Health Sciences, Inc.
|
U.S.A.
|
Renewal
|
22 March 2023
|
11 April 2028
|
View |
|
DR-XY46306
|
Ascorbic acid (as calcium ascorbate, potassium ascorbate, magnesium ascorbate, and zinc ascorbate) + Citrus bioflavonoids extract + Rutin + Quercetin dihydrate
|
Poly C
|
600mg/ 65mg/ 7mg/ 3mg
|
Film-Coated Tablet
|
Vitamins
|
USANA Health Sciences Inc.
|
U.S.A.
|
Renewal
|
22 March 2023
|
05 April 2028
|
View |
|
DR-XY46310
|
Multivitamins + Minerals + Amino Acids
|
None
|
[see reverse]
|
Tablet
|
Vitamin
|
United Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
08 July 2022
|
10 April 2028
|
View |
DR-XY46317_PI_01.pdf
|
DR-XY46317
|
Sacubitril-Valsartan
|
Vymada
|
50mg (eq. to sacubitril 24.3mg and valsartan 25.7mg sodium salt complex)
|
Film-Coated Tablet
|
Angiotensin Receptor-Neprilysin Inhibitor
|
Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd.
|
Singapore
|
Monitored Release
|
02 May 2018
|
02 May 2025
|
View |
DR-XY46318_PI_01.pdf
|
DR-XY46318
|
Sacubitril-Valsartan
|
Vymada
|
100mg (eq. to sacubitril 48.6mg and valsartan 51.4mg sodium salt complex)
|
Film-Coated Tablet
|
Angiotensin Receptor-Neprilysin Inhibitor
|
Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd.
|
Singapore
|
Monitored Release
|
02 May 2018
|
02 May 2025
|
View |
DR-XY46319_PI_01.pdf
|
DR-XY46319
|
Sacubitril-Valsartan
|
Vymada
|
200mg (eq. to sacubitril 97.2mg and valsartan 102.8mg sodium salt complex)
|
Film-Coated Tablet
|
Angiotensin Receptor-Neprilysin Inhibitor
|
Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd.
|
Singapore
|
Monitored Release
|
02 May 2018
|
02 May 2025
|
View |
|
DR-XY46320
|
Meropenem
|
None
|
500 mg
|
Powder for Injection
|
Antibacterial (Carbapenem)
|
Savior Lifetec Corporation (Tainan Branch Injection Plant)
|
China
|
Automatic Renewal
|
01 February 2023
|
26 April 2028
|
View |
|
DR-XY46321
|
Meropenem (as Trihydrate)
|
None
|
1g
|
Powder for Injection
|
Antibacterial (Carbapenem)
|
Savior Lifetec Corporation (Tainan Branch Injection Plant)
|
China
|
Automatic Renewal
|
11 February 2023
|
26 April 2028
|
View |
|
DR-XY46324
|
Metformin Hydrochloride
|
None
|
500mg
|
Film-Coated Tablet
|
Oral Hypoglycemic (Biguanide)
|
Celogen Pharma Pvt. Ltd.
|
India
|
Automatic Renewal
|
13 December 2022
|
02 May 2028
|
View |
|
DR-XY46325
|
Metformin Hydrochloride
|
None
|
850mg
|
Film-Coated Tablet
|
Oral Hypoglycemic (Biguanide)
|
Celogen Pharma Pvt. Ltd.
|
India
|
Automatic Renewal
|
28 November 2022
|
02 May 2028
|
View |
|
DR-XY46328
|
Gemigliptin
|
Zemiglo
|
50 mg
|
Film-Coated Tablet
|
Hypoglycemic
|
LG Chem, Ltd.
|
Korea
|
Compliance MR
|
04 May 2018
|
04 May 2025
|